Citation: T. Hovi et al., Poliovirus surveillance by examining sewage specimens. Quantitative recovery of virus after introduction into sewerage at remote upstream location, EPIDEM INFE, 127(1), 2001, pp. 101-106
Authors:
Vesa, S
Kleemola, M
Blomqvist, S
Takala, A
Kilpi, T
Hovi, T
Citation: S. Vesa et al., Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age, PEDIAT INF, 20(6), 2001, pp. 574-581
Citation: C. Savolainen et al., Molecular epidemiology of echovirus 30 in Europe: succession of dominant sublineages within a single major genotype, ARCH VIROL, 146(3), 2001, pp. 521-537
Citation: H. Sormunen et al., Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine, J MED VIROL, 63(4), 2001, pp. 305-310
Citation: A. Airaksinen et al., Coxsackievirus A9 VP1 mutants with enhanced or hindered A particle formation and decreased infectivity, J VIROLOGY, 75(2), 2001, pp. 952-960
Citation: T. Hovi et M. Stenvik, Surveillance of patients with acute flaccid paralysis in Finland: report of a pilot study, B WHO, 78(3), 2000, pp. 298-304
Authors:
Mulders, MN
Salminen, M
Kalkkinen, N
Hovi, T
Citation: Mn. Mulders et al., Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes, J GEN VIROL, 81, 2000, pp. 803-812
Authors:
Otonkoski, T
Roivainen, M
Vaarala, O
Dinesen, B
Leipala, JA
Hovi, T
Knip, M
Citation: T. Otonkoski et al., Neonatal Type I diabetes associated with maternal echovirus 6 infection: acase report, DIABETOLOG, 43(10), 2000, pp. 1235-1238
Authors:
Pitkaranta, A
Nokso-Koivisto, J
Jantti, V
Takala, A
Kilpi, T
Hovi, T
Citation: A. Pitkaranta et al., Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children, J CLIN VIRO, 14(3), 1999, pp. 199-205
Citation: S. Valtanen et al., Problems with biotin-labelled virions as probes in poliovirus-specific mu-capture-IgM assays, J CLIN VIRO, 14(1), 1999, pp. 17-23
Authors:
Rosenlew, M
Stenvik, M
Roivainen, M
Jarvenpaa, AL
Hovi, T
Citation: M. Rosenlew et al., A population-based prospective survey of newborn infants with suspected systemic infection: occurrence of sporadic enterovirus and adenovirus infections, J CLIN VIRO, 12(3), 1999, pp. 211-219
Authors:
Hirvonen, A
Mattson, K
Karjalainen, A
Ollikainen, T
Tammilehto, L
Hovi, T
Vainio, H
Pass, HI
Di Resta, I
Carbone, M
Linnainmaa, K
Citation: A. Hirvonen et al., Simian virus 40 (SV40)-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-Contaminated polio vaccines, MOL CARCINO, 26(2), 1999, pp. 93-99
Authors:
Piirainen, L
Stenvik, M
Roivainen, M
Eskola, J
Beuvery, EC
Hovi, T
Citation: L. Piirainen et al., Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus, VACCINE, 17(9-10), 1999, pp. 1084-1090
Authors:
Blomqvist, S
Skytta, A
Roivainen, M
Hovi, T
Citation: S. Blomqvist et al., Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription-PCR-hybridization assay, J CLIN MICR, 37(9), 1999, pp. 2813-2816